Results

Total Results: 1,185 records

Showing results for "author year description".

41. Frameworks for Determining Research Gaps During Systematic Reviews (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-research-steps-framework_research.pdf
    June 01, 2011 - We contacted the primary author of the evidence report. … If it was unclear who the primary author was, or if we were not able to contact the primary author, … (Year) Topic Area Ref Relevant Text From Article Summary of Method/Framework Used Chou (2009) … (Year) Topic Area Ref Relevant Text From Article Summary of Method/Framework Used Johnson (2003 … Over the course of the next year, we will be “harmonizing” our processes – with the likely end goal

42. Gorman_Asynchronous (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/gorman.pdf
    January 01, 2009 - www.effectivehealthcare.ahrq.gov/index.cfm) � Slide 7: Untitled • Description

43. Disposition of Comments_Comparative Effectiveness Review No. 261_Postpartum Care up to 1 Year After Pregnancy: A Systematic Review and Meta-analysis (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/postpartum-care-one-year-disposition-comments.pdf
    June 02, 2023 - Disposition of Comments_Comparative Effectiveness Review No. 261_Postpartum Care up to 1 Year After Pregnancy … Postpartum Care up to 1 Year After Pregnancy: A Systematic Review and Meta-Analysis. … field_product_type%3Amethods_guide_chapter&sort_by=field_product_pub_date Summary of Peer Reviewer Comments and Author … : June 2, 2023 3 Public Comments and Author Response Commenter Section Comment Response PCORI … https://effectivehealthcare.ahrq.gov/products/postpartum-care-one-year/research

44. Blood-based Tests for Multiple Cancer Screening: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-protocol.pdf
    June 05, 2024 - Logic Model An evidence synthesis on this topic within the coming year may not definitively answer the … KQ 3: At least 1 year of followup for prediagnostic performance designs.a For diagnostic performance … studies that use disease-free longitudinal followup as a reference standard should have a minimum of 1 year … Abstraction Elements KQ 1, 2, 4, and 5 Studies Question Text Type Answer Text Article Title Text Year … Sensitivity (95% CI) Author-reported Specificity (95% CI) Author-reported AUC (95% CI) Comments

45. Disposition of Comments for CER 196 The Role of Immunotherapy in the Treatment of Asthma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-196-disposition-comments-immunotherapy-asthma.pdf
    March 23, 2018 - Twelve-year survey of fatal reactions to allergen injections and skin testing 1990-2001. … Typical regimens for SLIT include daily home administration, with dosing regimens such as year round … Long-term follow-up of patients treated with a three-year course of cat or dog immunotherapy. … It is noted that this omission may bias outcome reporting for SLIT vs SCIT, based on year of publication … De Blay et al, 2014 (ref 74) was not adults only, the inclusion criteria was for patients aged 14 year

46. Disposition of Comments for Treatment Strategies for Patients With Peripheral Artery Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_disposition-comments.pdf
    May 29, 2013 - Definitions of the type of supervised exercise therapy vary across studies, but we have added a general description … however, suggest that “..amputation-free survival favored endovascular interventions with low SOE at 1 year … considerably better primary patency compared to endovascular treatments for CLI at intermediate (1 year … In the studies we reviewed, the RCTs and prospective observational studies had a description of how

47. Version-3-Immunity-After-Covid-19-Appendix-Table-B-1 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
    January 24, 2022 - KQ1_IgG Duration_n=3 Observational studies examining IgG Duration Author Year Title PMID Link/URL … Country Study Design Length of follow-up (Months) Population category Population Description Data … Description Data Source Study Period Inclusion criteria Exclusion criteria Total N Age: Mean (SD) … Population category Population description Data source Inclusion criteria Exclusion criteria Positive … ≤1 year after primary infection: 6,111 F/u >1 year after primary infection: 474 Unvaccinated only

48. Disposition of Comments for CER 164 Home-Based Primary Care Interventions (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/home-based-care_disposition-comments.pdf
    February 16, 2016 - We have revised the description of the Edes, 2014 study. Thank you. … • Reference 37 author Neergaard is not home-based primary care. … We revised the description of the Edes, 2014 study. … included, as it was one of three quality observational studies on outcomes in HBPC that came out last year … well known in the field that practices commonly experience mortality rates of 20-25% on average per year

49. Enhanced Functionality for the Distributed Research Network Pilot | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/distributed-network-expansion/research
    April 03, 2012 - Research Network Pilot Research Report April 3, 2012 Download Main Document PDF 2 MB Author … Metadata include years of data available, types of data available by year, key contacts, and special … Requirements and Design Specification Revision 1.5 April 26, 2010 Document History Revision Author … The SQL for the Enrollment query is as follows: SELECT * FROM Enrollment WHERE Year … Metadata will include years of data available, types of data available by year, key contacts, special

50. Patient Safety in Ambulatory Settings | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/ambulatory-safety/research-protocol
    July 30, 2015 - for the Technical Brief The Agency for Healthcare Research and Quality (AHRQ) is launching a multi-year … initiative in Fiscal Year 2015 to expand the scientific evidence, strategies, and tools that are available … Searches will begin with the year 2000. … for dual abstraction of study-level details based on the previous MHCS review, including intervention description … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

51. Rapid Evidence Product Addressing Social Isolation To Improve the Health of Older Adults A Rapid Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-social-isolation-older-adults-final.pdf
    February 01, 2019 - Physical activity interventions Author, Year Study Design Intervention Duration Country Study Quality … C-2 Author, Year Study Design Intervention Duration Country Study Quality Population Intervention … C-3 Author, Year Study Design Intervention Duration Country Study Quality Population Intervention … Arts and recreation interventions Author, Year Study Design Intervention Duration Country Study … Health services access interventions Author, Year Study Design Intervention Duration Country Study

52. Disposition of Comments Report for Evidence Report 215 Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_disposition-comments.pdf
    January 01, 2020 - We searched from a year before publication of the IOM report. … We searched from a year before the IOM search date. … The author should list the type of study conducted (i.e. controlled trial, cohort etc). … List author in study description The citation lists authors as the Italian Multi-center Study Group … We apologize for the earlier mistake of listing the author name in this table.

53. Disposition of Comments Report for Evidence Report 215 Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccine-safety_disposition-comments.pdf
    January 01, 2020 - We searched from a year before publication of the IOM report. … We searched from a year before the IOM search date. … The author should list the type of study conducted (i.e. controlled trial, cohort etc). … List author in study description The citation lists authors as the Italian Multi-center Study Group … We apologize for the earlier mistake of listing the author name in this table.

54. Disposition of Comments for CER 171 Noninvasive Testing for Coronary Artery Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/coronary-artery-disease-testing_disposition-comments.pdf
    March 29, 2016 - The initial description of anatomic and functional tests is on page 2 of the full report. … Further description of this may be helpful to the reader. Thank you for your comments. … appropriate and led to variable results for pretest risk, which sometimes were very different than the author-defined … TEP 5 General This was an extremely complex and audacious undertaking, and the author are to be congratulated … Description and discussion of costs, value and/or cost-effectiveness were not part of the scope of

55. Disposition of Comments Report for The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_disposition-comments.pdf
    September 29, 2014 - Given this description, there seems to be a broad degree of “quality” within this single category. … for Clinical and Policy Decisionmaking section, the first paragraph seems to represent an accurate description … We edited the typo where it should have said >1 year. … In Summary Tables A and 6, the conclusion column sometimes includes a brief description of the source … Peer Reviewer 7 Results Page ES-23, lines 18-23-here and in subsequent sections, the description of the

56. Project Name: (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_disposition-comments.pdf
    October 25, 2011 - Our description of an association has been improved. … This may be a problem with clarity of description rather than the actual data. … We have expanded our description of these concepts in the introduction and added the above text to … Our clinical expert stands by our description. … Increased Incidence of Cardiovascular Disease in Middle- aged Men with Obstructive Sleep Apnea: A 7- Year

57. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy_disposition-comments.pdf
    March 11, 2010 - Methods Your description of negative predictive value as applying to specific populations of women is … The description of how the strength of evidence was graded was accidently omitted from the draft report … Methods A description on strength of evidence should be added. … Results p.39 add more description of the methods used in these three studies.

58. A Framework for Conceptualizing Evidence Needs of Health Systems (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-framework-for-conceptualizing-evidence-needs_0.pdf
    December 01, 2017 - This description is analogous to the strength of evidence (SOE) levels used by the EPC program when … , Year Setting Findings Hartling 201710 Hartling 201533 U.S. … , Year Setting Findings (Anonymous) 201074 U.S. … C-6 First Author, Year Setting Findings Gifford 201442 Canada Evaluation of organizational … Goeree 200976 Canada Description of the Ontario HTA process • Health care facilities, community-based

59. Disposition of Comments for CER 170 Cultural Competence Health Disparities (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cultural-competence_disposition-comments.pdf
    January 01, 2020 - following UNCLEAR SENTENCE should be modified: Since evidence was sparse, qualitative analysis and description … TEP 3 Introduction Cultural Competence Section needs to include a description of the National Standards … Overall I found the description of what's eligible and what's not to be hard to follow given that there

60. Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers; Long-Term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/adhd_disposition-comments.pdf
    October 01, 2011 - 10 year earlier steeper change. … Rewritten, Adderall is approved for ≥3 year olds in USA, and ≥6 year olds in Canada p 27 of 278 Peer … Description of GRADE approach on page 25 would be useful. … Results Table 6, page 66 of 255, Ghuman 2007 study: Author’s first name initial is incorrect; the author … Results (5) Table 6, page 66 of 255, Ghuman 2007 study: Author’s first name initial is incorrect; the author